Gillian A Kingsbury

This inventor holds 9 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Millennium Pharmaceuticals Limited, Abbvie Inc.. Active years: 2001-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gillian A Kingsbury. Retrieved from https://idiyas.com/inventor/gillian-a-kingsbury

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 9)

% Patents Active = 33.3

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 1.7

ph-index = 7

Forward Citations = 206(Granted Patents)

Location History:

W. Roxbury, MA (US) (2006)
W Roxbury, MA (US) (2001 - 2008)
Roslindale, MA (US) (2006 - 2012)
Wayland, MA (US) (2011 - 2015)

Company Filing History:

8 out of 855

Millennium Pharmaceuticals Limited

Years Active: 2001-2015

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9029508 - Dual variable domain immunoglobulins and uses thereof (2015-05-12),

2. 8444987 - Compositions and methods for the diagnosis and treatment of immune disorders (2013-05-21),

3. 8163503 - Methods of identifying compounds that bind TANGO509 (2012-04-24),

4. 7972797 - Compositions and methods for the diagnosis and treatment of immune disorders (2011-07-05),

5. 7452980 - Compositions and methods for the diagnosis and treatment of immune disorders (2008-11-18),

6. 7385036 - Human tango 509 polypeptides (2008-06-10),

7. 7041474 - Nucleic acid encoding human tango 509 (2006-05-09),

8. 6989144 - Glycoprotein VI antibodies and uses thereof (2006-01-24),

9. 6323334 - Nucleic acid molecules encoding a 103 gene product and uses therefor (2001-11-27),

Title: Gillian A Kingsbury: Innovator in Immunology

Introduction

Gillian A Kingsbury is a prominent inventor based in Wayland, MA (US), known for his significant contributions to the field of immunology. With a total of 9 patents to his name, Kingsbury has made remarkable strides in developing innovative solutions for immune disorders.

Latest Patents

Among his latest patents, Kingsbury has developed "Dual variable domain immunoglobulins and uses thereof." This invention focuses on engineered multivalent and multispecific binding proteins, which are crucial for the prevention, diagnosis, and treatment of various diseases. Another notable patent is "Compositions and methods for the diagnosis and treatment of immune disorders." This invention details methods and compositions specifically aimed at treating and diagnosing immune disorders, particularly those related to T helper lymphocyte subpopulations. The invention highlights the 103 gene, which is differentially expressed in TH2 cells, and its potential as a target for therapeutic intervention in immune disorders such as allergies and asthma.

Career Highlights

Throughout his career, Kingsbury has worked with leading companies in the pharmaceutical industry, including Millennium Pharmaceuticals Limited and AbbVie Inc. His work has significantly impacted the development of therapies for immune-related conditions, showcasing his expertise and dedication to advancing medical science.

Collaborations

Kingsbury has collaborated with notable professionals in his field, including Kevin R Leiby and Tariq Ghayur. These collaborations have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Gillian A Kingsbury stands out as a key figure in immunology, with a strong portfolio of patents that address critical health challenges. His work continues to influence the landscape of medical research and treatment options for immune disorders.

Profile summary based on public USPTO records.